Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 20, 1032-1040, August 1, 1960]
© 1960 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warwick, O. H.
Right arrow Articles by Noble, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warwick, O. H.
Right arrow Articles by Noble, R. L.

Some Biological Effects of Vincaleukoblastine, an Alkaloid in Vinca rosea Linn in Patients with Malignant Disease*

O. H. Warwick, J. M. M. Darte, T. C. Brown, C. T. Beer, J. H. Cutts and R. L. Noble{dagger}

( The Ontario Cancer Institute and Princess Margaret Hospital, Toronto, Ontario)

The treatment of 22 patients with Vincaleukoblastine is described. The main toxic effects were noted at the sites of injection, on the blood, and on the nervous system. Severe granulocytopenia with little or no depression of platelets was noted in nearly all patients. In fifteen of the 22 patients the administration of Vincaleukoblastine had measurable effects on the malignant process. Partial remissions of short duration, with marked improvement in general clinical condition, were obtained in three children with acute leukemia, in one patient with lymphosarcoma, and in one with breast cancer.

* This investigation was supported by grants from the Ontario Cancer Treatment and Research Foundation.

{dagger} The Collip Medical Research Laboratory, University of Western Ontario, London, Canada.

Received 1/11/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1960 by the American Association for Cancer Research.